RBC Capital Starts Salix Pharmaceuticals (SLXP) at Outperform
Tweet Send to a FriendGet Alerts SLXP Hot Sheet
Price: $58.75 --0%
Rating Summary:
10 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 7 | New: 8
Rating Summary:
10 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 7 | New: 8
Trade SLXP Now!
RBC Capital initiates coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with a Outperform. PT $53.00.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $45.59 yesterday, with a 52 week range of $37.52-$55.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $45.59 yesterday, with a 52 week range of $37.52-$55.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- BofA/Merrill Lynch Starts Franklin Street Properties (FSP) at Neutral
- Ladenburg Thalmann Starts EV Energy Partners (EVEP) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
